The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Sep. 24, 2018
Applicant:

The University of North Carolina AT Chapel Hill, Chapel Hill, NC (US);

Inventors:

Soumya Rahima Benhabbour, Chapel Hill, NC (US);

Rima Janusziewicz, Carrboro, NC (US);

Sue J. Mecham, Chapel Hill, NC (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); B33Y 30/00 (2015.01); B29C 64/124 (2017.01); A61K 31/675 (2006.01); B29C 64/00 (2017.01); A61M 31/00 (2006.01); B33Y 70/00 (2020.01); B33Y 80/00 (2015.01); A61F 6/08 (2006.01); A61K 31/566 (2006.01); B33Y 10/00 (2015.01); B29C 64/135 (2017.01); B29K 105/00 (2006.01); B29K 283/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0036 (2013.01); A61F 6/08 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 31/675 (2013.01); A61M 31/00 (2013.01); A61M 31/002 (2013.01); B29C 64/00 (2017.08); B29C 64/124 (2017.08); B33Y 30/00 (2014.12); B33Y 70/00 (2014.12); B33Y 80/00 (2014.12); A61K 31/566 (2013.01); A61M 2207/00 (2013.01); B29C 64/135 (2017.08); B29K 2105/0035 (2013.01); B29K 2283/00 (2013.01); B29K 2995/0093 (2013.01); B29L 2031/753 (2013.01); B33Y 10/00 (2014.12);
Abstract

Geometrically complex intravaginal rings, systems and methods of making the same are provided herein. Disclosed herein are geometrically complex intravaginal rings with tunable and enhanced drug release, which in some embodiments can be fabricated by 3D printing technologies. The disclosed IVRs include a ring structure comprising a plurality of unit cells or macroscopic and/or microscopic architecture, which can be tuned to control the loading capacity of an active compound within the IVR, the diffusion of an active compound from the IVR, the surface area of the IVR, and/or the mechanical properties of the IVR. The disclosed geometrically complex IVRs can provide superior control over drug loading and drug release compared to conventional IVRs fabricated by injection molding or hot-melt extrusion.


Find Patent Forward Citations

Loading…